Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gong-Rak Lee

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2019
Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome functionHye In Lee, Jiae Lee, Donghyun Hwang, et al.
Journal of Cellular Physiology|June 30, 2021
Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesisHyun Jin Kim, Jiae Lee, Gong-Rak Lee, et al.
Acta Pharmaceutica Sinica. B|March 7, 2020
Benzydamine inhibits osteoclast differentiation and bone resorption <i>via</i> down-regulation of interleukin-1 <i></i> expressionHan Saem Son, Jiae Lee, Hye In Lee, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2018
Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signalingJiae Lee, Han Saem Son, Hye In Lee, et al.
Free Radical Biology & Medicine|August 5, 2017
Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclastSeong-Eun Hong, Jiae Lee, Dong-Hyun Seo, et al.
Journal of Cellular Physiology|July 24, 2020
Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesisYou-Jin Jo, Hye In Lee, Narae Kim, et al.
Free Radical Biology & Medicine|January 2, 2016
Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damageHojin Kim, Gong-Rak Lee, Jiwon Kim, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2019
Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome functionHye In Lee, Jiae Lee, Donghyun Hwang, et al.
Journal of Cellular Physiology|June 30, 2021
Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesisHyun Jin Kim, Jiae Lee, Gong-Rak Lee, et al.
Acta Pharmaceutica Sinica. B|March 7, 2020
Benzydamine inhibits osteoclast differentiation and bone resorption <i>via</i> down-regulation of interleukin-1 <i></i> expressionHan Saem Son, Jiae Lee, Hye In Lee, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2018
Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signalingJiae Lee, Han Saem Son, Hye In Lee, et al.
Free Radical Biology & Medicine|August 5, 2017
Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclastSeong-Eun Hong, Jiae Lee, Dong-Hyun Seo, et al.
Journal of Cellular Physiology|July 24, 2020
Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesisYou-Jin Jo, Hye In Lee, Narae Kim, et al.
Free Radical Biology & Medicine|January 2, 2016
Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damageHojin Kim, Gong-Rak Lee, Jiwon Kim, et al.
Pageof 2